| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.005 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |